Success Story: Advancing AI-Enabled Precision Cardiology: NIW Approved for a Portuguese Postdoctoral Scholar Developing Multi-Omics and Machine Learning Tools for Cardiovascular and Multi-Organ Syndromes
On January 5th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Scholar in the field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Postdoctoral Scholar
Country of Origin: Portugal
State of Residence at the Time of Filing: California
Approval Notice Date: January 5th, 2026
Processing Time: 1 year, 11 months, 7 days
Case Summary:
This NIW approval features a Portuguese postdoctoral scholar whose work bridges medical science with advanced computational methods to strengthen cardiovascular care. The proposed endeavor focuses on developing artificial intelligence techniques and multi-omics analysis to better understand cardiovascular and multi-organ syndromes, with the goal of improving risk prediction, enabling more individualized medicine, and supporting novel therapeutic target discovery. At the time of filing, the client was continuing this work in the United States through a postdoctoral research appointment aligned with the endeavor.
Research with National Importance
In the petition, we demonstrated substantial merit and national importance by linking the endeavor to major U.S. priorities in healthcare outcomes and innovation. As cardiovascular conditions remain a leading driver of morbidity, mortality, and healthcare utilization, improved risk prediction and earlier identification of disease patterns can strengthen clinical decision-making and resource allocation. We also emphasized that the endeavor advances capabilities in AI, machine learning, and biomedical analytics, areas that support U.S. scientific leadership and patient-centered care.
Academic Contributions and Recognition
The petition documented a strong and privacy-protective record of scholarly output and independent impact. The client has authored 13 peer-reviewed journal articles and 1 preprint, and this work has been cited 155 times, reflecting meaningful reliance by other researchers. To demonstrate influence beyond raw totals, we also highlighted citation-percentile evidence showing that multiple publications rank among the most-cited in their field for their publication periods.
Recognition from Experts
The filing included expert letters, including an independent advisory opinion, describing why the client’s research contributions are valuable beyond any single institution and how the work supports continued progress in AI-enabled cardiovascular research.
One expert observed:
“[Client]’s unique ability to merge medical science with advanced computational techniques positions her research as a pivotal contribution to the field.”
This endorsement reinforced the petition’s position that the client’s work is not only academically meaningful but also practically relevant to U.S. healthcare priorities.NIW Approval and Outlook
The I-140 NIW petition was filed on January 29th, 2024, and approved on January 5th, 2026. In the filing, we presented a clear NIW framework showing that the endeavor has substantial merit and national importance, the client is well-positioned to advance it through an established publication and citation record, and that granting the waiver benefits the United States by supporting continued progress in data-driven, patient-centered cardiovascular care.